VEGFA and polycystic ovary syndrome: The use of dopamine agonists is based upon animal models of OHSS and evidence of low-dopamine tone in PCOS patients leading to dysregulated VEGF signaling (the key factor behind the pathogenesis of OHSS) [65, 66].